Type I, II, III Collagen: Do the Types Actually Matter?

Collagen Peptides

28 types

At least 28 genetically distinct collagen types have been identified in humans, but types I, II, and III account for 80-90% of the collagen in your body.

Khatri et al., Nutrients, 2021

Khatri et al., Nutrients, 2021

View as image

Collagen supplement labels prominently display "Type I," "Type II," or "Type I and III" as if this distinction determines what the product does for your body. The marketing implies you should match the collagen type to your goal: types I and III for skin and bones, type II for joints. The biology behind these types is real. They are genetically distinct proteins with different structures and tissue distributions. But whether this distinction matters once collagen is hydrolyzed into peptides and digested is a separate question, and the answer is more complicated than the labels suggest. Understanding the differences between the 28 known collagen types starts with the three that dominate: types I, II, and III. These account for 80-90% of all collagen in the human body, and they are the foundation of the collagen supplement market.

Type I: the structural workhorse

Type I collagen is the most abundant protein in the human body. It accounts for approximately 90% of total collagen and is the dominant structural protein in skin, bones, tendons, ligaments, the cornea, and the organic matrix of teeth. The molecule consists of two alpha-1 chains and one alpha-2 chain wound into a triple helix, which then assembles into thick, tightly packed fibrils that resist tensile force.^[1]

In skin, type I fibrils form a dense meshwork in the dermis that provides tensile strength and structural support. As skin ages, type I collagen production declines by approximately 1% per year after age 30, and existing fibrils fragment under UV exposure and oxidative stress. This loss of type I collagen is the primary structural change behind wrinkles, sagging, and thinning skin.^[2]

In bone, type I collagen makes up 90% of the organic matrix and provides the framework onto which hydroxyapatite crystals deposit. The collagen network gives bone its flexibility and resistance to fracture, while the mineral phase provides hardness. Loss of type I collagen quality (not just mineral density) is a major contributor to osteoporotic fracture risk, which is why collagen peptides for bone density are an active research area.

Dierckx and colleagues demonstrated in 2024 that specific collagen peptides stimulated type I collagen gene expression (COL1A1) in cultured human dermal fibroblasts by 1.5-fold, along with increases in elastin and versican expression. This suggests that exogenous collagen peptides can signal fibroblasts to increase endogenous collagen production, not just supply raw amino acids.^[3]

Type II: the cartilage collagen

Type II collagen is a homotrimer, meaning all three chains in its triple helix are identical (three alpha-1 chains). It is the principal structural collagen of hyaline cartilage, comprising over 50% of cartilage dry weight. Type II fibrils are thinner and less densely packed than type I fibrils, creating a meshwork that entraps proteoglycans (primarily aggrecan), which draw water into the tissue and provide compressive resistance.^[4]

In osteoarthritis, the type II collagen network degrades progressively. Matrix metalloproteinases cleave the triple helix, and the resulting fragments are released into joint fluid and blood, where they serve as biomarkers of cartilage destruction. Once the type II network is disrupted, proteoglycans leach out, water content drops, and the cartilage loses its shock-absorbing capacity.

Lin and colleagues published a 2023 meta-analysis of randomized controlled trials examining collagen peptides for knee osteoarthritis. The pooled analysis found statistically significant improvements in pain scores (measured by VAS and WOMAC) with collagen supplementation versus placebo. The effect size was modest but consistent across trials.^[4]

Type II collagen is found almost exclusively in cartilage, the vitreous humor of the eye, and the nucleus pulposus of intervertebral discs. It does not appear in skin, bone, or tendons in meaningful amounts. This tissue specificity is what drives the marketing claim that "type II collagen is for joints."

Type III: the elastic partner

Type III collagen is a homotrimer of three alpha-1 chains (distinct from type II's alpha-1 chains). It produces thinner, more elastic fibrils than type I and is found predominantly in tissues that require flexibility: blood vessel walls, the gastrointestinal tract, the uterus, and the reticular framework of lymphoid organs like the spleen and lymph nodes.^[5]

In skin, type III collagen typically coexists with type I. Fetal skin is rich in type III (about 50% of dermal collagen), and this ratio shifts toward type I dominance during postnatal development. Adult skin contains approximately 80% type I and 20% type III. The type III component contributes to skin's elasticity and pliability, while type I provides tensile strength. Both decline with age.

Demir-Dora and colleagues published a 2025 clinical study of type I and III hydrolyzed collagen peptides for skin health. The 12-week supplementation trial showed improvements in skin hydration, elasticity, and wrinkle depth compared to placebo. The study used a collagen source (bovine dermis) that naturally contains both types I and III, which is the standard composition of most bovine and porcine collagen supplements.^[5]

Type III collagen also plays a critical role in wound healing. During the proliferative phase of repair, fibroblasts initially produce type III collagen to form a provisional matrix. Over weeks to months, this type III matrix is gradually replaced by type I collagen in a process called remodeling. The ratio of type III to type I at a wound site shifts from about 30:70 initially to the normal 20:80 as the scar matures. This is one reason collagen supplementation is studied for post-surgical tissue repair.

What happens when collagen is hydrolyzed

This is where the type-specific marketing runs into a biological problem. When collagen of any type is hydrolyzed for supplements, enzymes break the triple helix into short peptide fragments, typically 2-10 amino acids long. The dominant bioactive fragments that survive digestion and appear in blood are di- and tripeptides: prolyl-hydroxyproline (Pro-Hyp), hydroxyprolyl-glycine (Hyp-Gly), and related sequences.^[6]

Sato and colleagues reported in 2020 that Pro-Hyp, the most abundant collagen-derived dipeptide in human blood after oral supplementation, acts as a growth factor for specific cell types including fibroblasts and chondrocytes. The dipeptide stimulates cell proliferation and extracellular matrix production through receptor-mediated signaling, not simply by supplying amino acids.^[6]

The critical point: Pro-Hyp and Hyp-Gly are produced from the hydrolysis of type I, type II, and type III collagen alike. The Gly-X-Y repeat structure that defines all fibrillar collagens generates the same bioactive dipeptides regardless of which type the source collagen was. Hydrolyzed collagen absorption follows the same pathway regardless of original type.

Lee and colleagues demonstrated in 2019 that orally administered collagen peptides protected against UV-induced skin aging in mice through the absorption of dipeptide forms Pro-Hyp and Hyp-Gly. The source was fish collagen (predominantly type I), but the active metabolites in blood were the same dipeptides found after ingesting bovine collagen (types I and III) or chicken collagen (type II).^[7]

This does not mean collagen type is entirely irrelevant. The relative abundance of specific tripeptide sequences differs slightly between types, and some less common peptides may have type-specific activities. But the dominant bioactive fragments that reach the bloodstream are shared across types.

The exception: undenatured type II collagen

There is one context where collagen type genuinely matters, and it has nothing to do with supplying building blocks. Undenatured type II collagen (UC-II) is a non-hydrolyzed preparation that preserves the native triple-helical structure of type II collagen. It works through oral immune tolerance: small doses of intact type II collagen presented to gut-associated lymphoid tissue train the immune system to reduce its attack on cartilage-derived antigens in the joints.^[4]

UC-II is taken at low doses (40 mg/day) compared to hydrolyzed collagen (5-15 g/day). The mechanism is immunological, not nutritional. And it only works with intact type II collagen because the immune tolerance effect depends on the specific epitopes present on the native type II molecule. This is a genuinely type-specific application, but it is fundamentally different from what hydrolyzed collagen supplements do.

Genc and colleagues published a 2025 study directly comparing type I/III collagen peptides with type II hydrolyzed collagen for osteoarthritis. Both improved pain and physical function scores, with no statistically significant difference between them. This suggests that for hydrolyzed collagen supplements, the type distinction may not matter as much as the dose and consistent use.^[8]

What the meta-analyses show about collagen type

Myung and colleagues published a 2025 systematic review and meta-analysis of 26 randomized controlled trials examining collagen peptide supplements and skin aging. The pooled analysis found improvements in skin hydration and elasticity. The studies used a mix of collagen sources (bovine, marine, porcine) containing different type compositions, but the meta-analysis found no clear evidence that one source or type profile was superior to another.^[9]

De Miranda and colleagues had reached a similar conclusion in their 2021 systematic review and meta-analysis of hydrolyzed collagen for skin aging: the positive effects on hydration and elasticity were consistent across studies regardless of collagen source or type composition.^[2]

For joint pain, the evidence is more nuanced. Some studies compare UC-II (undenatured type II, immune mechanism) directly against hydrolyzed collagen (mixed types, nutritional mechanism) and find UC-II at 40 mg outperforms 10 g of hydrolyzed collagen for joint pain scores. This is not a type I vs. type II comparison; it is a comparison of two entirely different mechanisms.

The honest summary: for hydrolyzed collagen supplements, the clinical evidence does not convincingly show that type-specific products outperform mixed-type products. The bioactive peptides that reach your blood after digestion are largely the same regardless of source. For undenatured type II collagen, the type genuinely matters because the mechanism is immunological, not nutritional. The source of collagen (marine vs. bovine) may matter more for sustainability, allergen profile, and peptide composition than the type label on the bottle.

Pueyo-Arias and colleagues noted in their 2025 narrative review that collagen supplementation shows promise across multiple health domains, but the field suffers from heterogeneity in doses, types, sources, and study designs that make type-specific recommendations premature.^[10]

The Bottom Line

Types I, II, and III collagen are genetically distinct proteins with different structures and tissue locations. Type I dominates skin and bone, type II is concentrated in cartilage, and type III provides elasticity to blood vessels and organs. When hydrolyzed for supplements, all three types yield similar bioactive dipeptides (Pro-Hyp, Hyp-Gly) that reach the bloodstream. Clinical evidence does not clearly support type-specific supplements over mixed-type products for most applications. The exception is undenatured type II collagen, which works through immune tolerance rather than nutrient supply and requires intact type II epitopes.

Frequently Asked Questions

What is the difference between type 1 2 and 3 collagen?

Type I collagen provides tensile strength to skin, bones, and tendons and makes up 90% of the body's collagen. Type II collagen forms the fibrillar network of cartilage, constituting over 50% of cartilage dry weight. Type III collagen provides elasticity to blood vessels, the GI tract, and the uterus. They are encoded by different genes and have different chain compositions, but all share the Gly-X-Y triple helix structure.^[1]

Does it matter what type of collagen you take?

For hydrolyzed collagen supplements, the type distinction appears to matter less than the dose. Once collagen is hydrolyzed, the bioactive dipeptides (Pro-Hyp, Hyp-Gly) that enter your bloodstream are the same regardless of original type. Meta-analyses show similar benefits across different collagen sources and types. The one exception is undenatured type II collagen (UC-II), which works through immune tolerance and requires intact type II collagen molecules.^[9]

Which collagen type is best for skin?

Bovine and marine collagen supplements, which are predominantly type I (with some type III in bovine), have the most clinical evidence for skin benefits. A 2025 meta-analysis of 26 RCTs found improvements in hydration and elasticity, but no clear superiority of one source or type over another. The evidence supports hydrolyzed collagen peptides at 2.5-10 grams daily rather than a specific type for skin outcomes.^[9]

Which collagen type is best for joints?

Two different approaches exist. Hydrolyzed collagen (any type, 5-15 g/day) provides bioactive peptides that stimulate chondrocyte activity and cartilage matrix production. Undenatured type II collagen (UC-II, 40 mg/day) works through oral immune tolerance to reduce the immune-mediated cartilage destruction seen in osteoarthritis. Some studies suggest UC-II outperforms hydrolyzed collagen for joint pain scores, but these are different mechanisms, not a type comparison.^[4]

Is type 1 and 3 collagen the same as type 2?

No. Type I and III collagen are often sold together because they are both abundant in bovine dermis (skin-derived collagen). Type II collagen comes from cartilage sources, primarily chicken sternum. Types I and III support skin, bone, and connective tissue. Type II supports cartilage. When hydrolyzed, however, they produce overlapping sets of bioactive peptides, particularly Pro-Hyp and Hyp-Gly.^[6]

How much collagen should you take per day?

Clinical trials have used doses ranging from 2.5 grams to 15 grams per day for hydrolyzed collagen peptides, with dosing studies showing benefits across this range depending on the outcome measured. Skin studies typically use 2.5-10 g/day; joint and bone studies use 5-15 g/day. Undenatured type II collagen (UC-II) is dosed at just 40 mg/day because its mechanism is immunological, not nutritional.^[8]